Bénéfices
| Q1 2025 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.620 | 0.890 | 0.2700 |
| Révision: | $312.09M | $193.10M | $9.07M |
| Q4 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.790 | 0.700 | -0.0900 |
| Révision: | $309.17M | $186.75M | -$6.51M |
| Q3 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.260 | 0.590 | -0.6700 |
| Révision: | $291.91M | $191.76M | $7.35M |
| Q2 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.740 | 0.460 | -0.2800 |
| Révision: | $220.45M | $163.45M | -$5.49M |
